M&A Deal Summary |
|
---|---|
Date | 2024-07-18 |
Target | Invetx |
Sector | Life Science |
Buyer(s) | Dechra Pharmaceuticals |
Sellers(s) | Eight Roads |
Deal Type | Add-on Acquisition |
Deal Value | 520M USD |
Advisor(s) | BofA Securities (Financial) Latham & Watkins (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1997 |
Sector | Life Science |
Revenue | 682M GBP (2022) |
Dechra Pharmaceuticals is an international specialist in veterinary pharmaceuticals and related products business. Its expertise is in the development, manufacturing, sales, and marketing of quality products exclusively for veterinarians worldwide. The company's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Dechra Pharmaceuticals was founded in 1997 and is based in Northwich, United Kingdom.
DEAL STATS | # |
---|---|
Overall | 16 of 16 |
Sector (Life Science) | 14 of 14 |
Type (Add-on Acquisition) | 14 of 14 |
State (Massachusetts) | 1 of 1 |
Country (United States) | 5 of 5 |
Year (2024) | 1 of 1 |
Size (of disclosed) | 1 of 12 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-08-30 |
Med-Pharmex
Pomona, California, United States Med-Pharmex is a manufacturer of pharmaceutical products for the animal health market which includes companion and food-producing animals. Med-Pharmex was founded in 1983 and is based in Pomona, California. |
Buy | - |
Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.
DEAL STATS | # |
---|---|
Overall | 96 of 98 |
Sector (Life Science) | 49 of 49 |
Type (Add-on Acquisition) | 43 of 45 |
State (Massachusetts) | 26 of 26 |
Country (United States) | 59 of 60 |
Year (2024) | 2 of 4 |
Size (of disclosed) | 6 of 19 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-04-03 |
Ujala Cygnus Healthcare Services
New Delhi, India Ujala Cygnus Healthcare Services provides multi-specialty care in orthopaedics, neurology, cardiology, gastro, and trauma related emergency care. Ujala Cygnus Healthcare Services was founded in 2011 and is based in New Delhi, India. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-07-23 |
Planck
New York, New York, United States Planck is a commercial insurance data platform, built to enable insurers to instantly and accurately underwrite any business. Planck's technology platform aggregates and mines massive datasets, using the latest advances in artificial intelligence to automatically generate and deliver key insights customized to the commercial underwriting process. Planck was founded in 2016 and is based in New York City. |
Sell | - |